Skye Bioscience Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.82

+0.02 (+2.48%)

As of Feb 8, 2:23 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 79%

Hold 3 21%

Sell 0 0%

Price Target

Analyst Price Target +1,840.7% upside

Low Target $11.92

Average Target $15.90

High Target $19.90

Current Price $0.82

Current
$0.82

Target
$15.90

$11.92 $15.90 avg $19.90

Scenario Analysis

Bear Case

$11.92

1,354.9%

Low target

Base Case

$15.90

+1,840.7%

Avg target

Bull Case

$19.90

+2,328.9%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$19.44

-95.8% from high

52-Week Low

$6.97

+-88.2% from low

Target vs 52W High

$15.90

-18.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%